IBDEI0XI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14922,1,3,0)
 ;;=3^Disease of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,14922,1,4,0)
 ;;=4^K76.9
 ;;^UTILITY(U,$J,358.3,14922,2)
 ;;=^5008836
 ;;^UTILITY(U,$J,358.3,14923,0)
 ;;=K76.7^^85^836^63
 ;;^UTILITY(U,$J,358.3,14923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14923,1,3,0)
 ;;=3^Hepatorenal syndrome
 ;;^UTILITY(U,$J,358.3,14923,1,4,0)
 ;;=4^K76.7
 ;;^UTILITY(U,$J,358.3,14923,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,14924,0)
 ;;=T86.49^^85^836^67
 ;;^UTILITY(U,$J,358.3,14924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14924,1,3,0)
 ;;=3^Liver transplant complication,Other
 ;;^UTILITY(U,$J,358.3,14924,1,4,0)
 ;;=4^T86.49
 ;;^UTILITY(U,$J,358.3,14924,2)
 ;;=^5055728
 ;;^UTILITY(U,$J,358.3,14925,0)
 ;;=K75.81^^85^836^75
 ;;^UTILITY(U,$J,358.3,14925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14925,1,3,0)
 ;;=3^Nonalcoholic steatohepatitis (NASH)
 ;;^UTILITY(U,$J,358.3,14925,1,4,0)
 ;;=4^K75.81
 ;;^UTILITY(U,$J,358.3,14925,2)
 ;;=^5008828
 ;;^UTILITY(U,$J,358.3,14926,0)
 ;;=E80.4^^85^836^33
 ;;^UTILITY(U,$J,358.3,14926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14926,1,3,0)
 ;;=3^Gilbert Syndrome
 ;;^UTILITY(U,$J,358.3,14926,1,4,0)
 ;;=4^E80.4
 ;;^UTILITY(U,$J,358.3,14926,2)
 ;;=^5002987
 ;;^UTILITY(U,$J,358.3,14927,0)
 ;;=Z20.5^^85^836^28
 ;;^UTILITY(U,$J,358.3,14927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14927,1,3,0)
 ;;=3^Exposure to Viral Hepatitis
 ;;^UTILITY(U,$J,358.3,14927,1,4,0)
 ;;=4^Z20.5
 ;;^UTILITY(U,$J,358.3,14927,2)
 ;;=^5062767
 ;;^UTILITY(U,$J,358.3,14928,0)
 ;;=R16.1^^85^836^82
 ;;^UTILITY(U,$J,358.3,14928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14928,1,3,0)
 ;;=3^Splenomegaly NEC
 ;;^UTILITY(U,$J,358.3,14928,1,4,0)
 ;;=4^R16.1
 ;;^UTILITY(U,$J,358.3,14928,2)
 ;;=^5019249
 ;;^UTILITY(U,$J,358.3,14929,0)
 ;;=D69.6^^85^836^84
 ;;^UTILITY(U,$J,358.3,14929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14929,1,3,0)
 ;;=3^Thrombocytopenia,Unspec
 ;;^UTILITY(U,$J,358.3,14929,1,4,0)
 ;;=4^D69.6
 ;;^UTILITY(U,$J,358.3,14929,2)
 ;;=^5002370
 ;;^UTILITY(U,$J,358.3,14930,0)
 ;;=K72.91^^85^836^37
 ;;^UTILITY(U,$J,358.3,14930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14930,1,3,0)
 ;;=3^Hepatic Failure w/o Coma
 ;;^UTILITY(U,$J,358.3,14930,1,4,0)
 ;;=4^K72.91
 ;;^UTILITY(U,$J,358.3,14930,2)
 ;;=^5008810
 ;;^UTILITY(U,$J,358.3,14931,0)
 ;;=C22.8^^85^836^73
 ;;^UTILITY(U,$J,358.3,14931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14931,1,3,0)
 ;;=3^Malignant Neop Liver,Primary,Unspec Type
 ;;^UTILITY(U,$J,358.3,14931,1,4,0)
 ;;=4^C22.8
 ;;^UTILITY(U,$J,358.3,14931,2)
 ;;=^5000939
 ;;^UTILITY(U,$J,358.3,14932,0)
 ;;=K86.0^^85^837^31
 ;;^UTILITY(U,$J,358.3,14932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14932,1,3,0)
 ;;=3^Pancreatitis,Chronic Alcohol
 ;;^UTILITY(U,$J,358.3,14932,1,4,0)
 ;;=4^K86.0
 ;;^UTILITY(U,$J,358.3,14932,2)
 ;;=^5008888
 ;;^UTILITY(U,$J,358.3,14933,0)
 ;;=K86.1^^85^837^32
 ;;^UTILITY(U,$J,358.3,14933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14933,1,3,0)
 ;;=3^Pancreatitis,Chronic,Other
 ;;^UTILITY(U,$J,358.3,14933,1,4,0)
 ;;=4^K86.1
 ;;^UTILITY(U,$J,358.3,14933,2)
 ;;=^5008889
 ;;^UTILITY(U,$J,358.3,14934,0)
 ;;=K86.2^^85^837^6
 ;;^UTILITY(U,$J,358.3,14934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,14934,1,3,0)
 ;;=3^Cyst of pancreas
 ;;^UTILITY(U,$J,358.3,14934,1,4,0)
 ;;=4^K86.2
 ;;^UTILITY(U,$J,358.3,14934,2)
 ;;=^5008890
 ;;^UTILITY(U,$J,358.3,14935,0)
 ;;=K86.3^^85^837^33
